Skip to main content
. 2021 Apr 7;124(11):1803–1808. doi: 10.1038/s41416-021-01368-z

Fig. 2. Clinical outcome by neutrophil to lymphocyte ratio change.

Fig. 2

Kaplan–Meier survival curves of progression-free survival and overall survival by change of neutrophil to lymphocyte ratio between baseline and week 3 of <0.9 vs ≥0.9. NLR neutrophil to lymphocyte ratio.